Congestive Heart Failure The Road to Recovery Philip D Houck M.D. - PowerPoint PPT Presentation

1 / 42
About This Presentation
Title:

Congestive Heart Failure The Road to Recovery Philip D Houck M.D.

Description:

Last Pearl Good is Better The Enemy of Good is Better i.e. -Watermelon Syncope Impella LV Assist Device External Counterpulsation Cardiac Transplantation Ventricular ... – PowerPoint PPT presentation

Number of Views:300
Avg rating:3.0/5.0
Slides: 43
Provided by: PHO82
Category:

less

Transcript and Presenter's Notes

Title: Congestive Heart Failure The Road to Recovery Philip D Houck M.D.


1
(No Transcript)
2
Determinants of Myocardial Performance
  • Afterload - The resistance to flow. The size of
    the arterioles.
  • Which patient has the highest afterload? (A)
    120/80
  • (B) 220/80

3
Determinants of Myocardial Performance
  • Which patient has the highest afterload?
    (A) 120/80
  • (B) 220/80
  • (A) - EF 15 Pulmonary Edema cool skin
  • (B) - 15 y/o 18 min. of Bruce ETT

4
Determinants of Myocardial Performance
  • Which patient has the highest afterload? (A)
    120/80
  • (A) - EF 15 Pulmonary Edema cool skin cardiac
    out put is 3 l/min

5
Determinants of Myocardial Performance
  • Afterload SVR (Mean BP - CVP) 80/CO
  • (A) - EF 15 Pulmonary Edema cool skin SVR
    (93.3-10)80/3 2222
  • (B) - 15 y/o 18 min. of Bruce ETT
  • SVR (126.6-5)80/20 486

6
Determinants of Myocardial Performance
  • Afterload SVR (Mean BP - CVP) 80/CO
  • or
  • Cardiac output Mean BP80/SVR
  • Cardiac output in patients even with low blood
    pressure can be increased by lowering SVR
  • Do not be afraid of gradually increasing ACEI
  • Cardiac output should be high
  • More medication is therefore good

7
Determinants of Myocardial Performance
  • Afterload - The resistance to flow
  • How do we decrease Afterload?

Vasodilators Nitroprusside, Natrecor
ACEI / ARB
Hydralazine/Nitrates Mechanical Balloon Pump
8
Determinants of Myocardial Performance
  • Contractility Inotropy
  • The speed and shortening capacity of the
    myocardium

9
Determinants of Myocardial Performance
  • Contractility Inotropy
  • The speed and shortening capacity of the
    myocardium
  • How is contractility increased?
  • The only oral agent - Digoxin
  • IV - Beta Agonist - Epinephrine Dopamine
    Levophed Dobtuamine Isuprel
  • - Phosphodiesterase Inhibitors -
    Amrinone Milrinone
  • Viagra

10
Determinants of Myocardial Performance
  • Compliance Lusitropy - the ability of the
    heart to fill

Pericardium
11
Determinants of Myocardial Performance
  • Compliance Lusitropy - the ability of the
    heart to fill

LVH, infiltrative excess calcium
12
Diastolic Heart Failure
25
15
5
vol1
vol2
13
Determinants of Myocardial Performance
  • Compliance Lusitropy - the ability of the
    heart to fill.
  • How can we improve Compliance?
  • Natrecor
  • Spironolactone
  • Ranolazine

14
Physical Exam
  • Preload JVD (R), S3 and/or rales (L)
  • Afterload Carotid pulse (L), systolic pulmonary
    artery tap (R)
  • Contractility PMI (L)
  • Compliance S4 (R)
  • These simple physical findings should completely
    describe the hearts performance
  • and determines the medications that help

15
Equation of Life
  • CO X Hgb O2 consumption / AV O2 difference
  • Cardiac output X Hemoglobin
  • The lower the blood count the higher the cardiac
    output
  • You can compensate for lower cardiac output by
    having a higher blood counts
  • Anemia (low blood count) is associated with CHF

16
Physical Examfor the equation of LIFE
17
How do CHF Patients suffer as they die?
  • Wide range of symptoms, which were frequently
    distressing and often lasted greater than 6
    months
  • Pain was most common in 50
  • Dyspnea was second most common
  • Low mood, anxiety
  • urinary incontinence

Living and dying with heart failure the role of
palliative care Gibbs, McCoy,Gibbs,Rogers,
Addington-Hall Heart 200288(supplII)ii36-ii39
18
How do your CHF Patients die?
  • Ventricular tachycardia/fibrillation
  • Pulseless electrical activity after a
    defibrillator shock
  • Pump failure low output
  • Sepsis from GI track due to bowel ischemia
  • Congestion and respiratory failure
  • Infection from skin breakdown
  • Liver or kidney failure
  • Inadequate reserve to meet extra demand

19
CHF patients can choose their mode of death
  • 28 of deaths can be avoided by defibrillator
    therapy
  • The mode of death changes to PEA, low out put,
    congestion or organ failure, failure to meet
    increase demands
  • Defibrillators are not for everyone

20
Strongest indicators of in-hospital death
Risk factor BUN (mg/dL) Systolic BP (mm Hg) Creatinine (mg/dL)
Predictive level gt43 lt115 gt2.75
Fonarow GC et al. JAMA 2005 293572-580.
21
(No Transcript)
22
Heart Failure in Women Overview
  • Affects older women disproportionately
  • Risk factors include hypertension, diabetes,
    obesity
  • More likely to have heart failure with preserved
    systolic function
  • Better prognosis than in men
  • Worrisome evidence of lesser responsiveness to
    ACE inhibitors similar responsiveness to
    b-blockers

23
Heart Failure in African Americans Overview
  • Affects 3 of the African American population
  • Atypical natural history
  • Unique epidemiology
  • Lower incidence of associated epicardial coronary
    artery disease
  • More likely to be associated with a historyof
    hypertension
  • Worrisome prognosis
  • Higher rate of hospitalization
  • Likely to have similar mortality risk
  • Question of altered responses to medical therapy

Yancy CW. J Card Fail. 20006183186.
24
Heart Failure in African Americans Etiology
  • Unique natural history
  • Occurs at an earlier age
  • Associated with more advanced left ventricular
    dysfunction at time of diagnosis
  • Worse clinical class at time of diagnosis
  • Higher incidence of left ventricular hypertrophy,
    especially concentric hypertrophy
  • Lack of definitive relationship between
    psychosocial factors and onset of disease

Yancy CW. J Card Fail. 20006183186.
25
Etiology of Heart Failure inAfrican Americans
Patients With Coronary Artery Disease-Based HF
80
60
40
Percent
20
0
V-HeFT I
V-HeFT II
SOLVD
US Carv
BEST
MERIT-HF
Patients With Hypertension-Based HF
80
60
Percent
40
20
0
V-HeFT I
V-HeFT II
SOLVD
US Carv
BEST
MERIT-HF
AA
non-AA
The BEST Investigators. N Engl J Med.
200134416591657 Packer M et al. N Engl J Med.
199633413491355 MERIT-HF Study Group. Lancet.
199935320012007 Cohn JN et al. N Engl J Med.
198631415471552Cohn JN et al. N Engl J Med.
1991325303310 The SOLVD Investigators. N Engl
J Med. 1991325293302.
26
Pearls
27
Pearls
  • Dizziness - reduce, D/C diuretics
  • Look for exacerbation reasons ( atrial
    arrhythmia, anemia, non-compliance)
  • CHF drives salt and fluid cravings - constantly
    remind your patients -daily weight
  • avoid NSAIDs (Advil Motrin)
  • erythropoiten is very good
  • Add Hydralazine/nitrates for failures consider
    ARB addition to ACE

28
How do you titrate all the medications?And what
order?
29
(No Transcript)
30
(No Transcript)
31
Pearls
32
Patient Flow
  • Hand off between hospital and out patient therapy
  • Titrate medications with compliance D/C
    Diuretic
  • Educate in salt, potassium, fluid balance, and
    weight
  • Not getting better Bi V Defibrillator
  • equation of life
  • Monitor for non compliance social/economic
    issue
  • Hydralazine /nitrate or ARB
  • Consider Geometric solutions control of ectopy
  • Prometheus EECP and stem Cells Co Q 10
  • Look for new endocrine failures for hypotension
  • Statins Statins Statins
  • Back off - Hospice or Transplant

33
Patient seems well with persistently elevated BNP
BNP Brain Naturetic Peptide - a Heart Hormone lt
120 heart is happy Can be compensated when
elevated Know your number
34
Last Pearl
  • Good is Better
  • The Enemy of Good is Better
  • i.e. -Watermelon Syncope

35
(No Transcript)
36
(No Transcript)
37
Impella LV Assist Device
38
External Counterpulsation
39
Cardiac Transplantation
40
Ventricular assist device
41
Stem Cells the Future
  • Regenerative Medicine
  • Control of Inflammation
  • Electrical Remodeling
  • The future is now Exercise increases stem cells

42
Summary
  • Heart failure is expensive and causes suffering
  • Heart Failure can improve with good life quality
  • Patients need to have good nutrition and avoid
    excess salt, fluids, calories
  • Patients need to take medications as prescribed
    and understand their purpose
  • Exercise 1 hour per day
  • Help your Doctors Nurses Dieticians with your
    complaints and work together for a solution
  • If these simple instructions are followed
    expensive operations might be avoided
Write a Comment
User Comments (0)
About PowerShow.com